Literature DB >> 3457949

Distribution of polyhexyl cyanoacrylate nanoparticles in nude mice bearing human osteosarcoma.

E M Gipps, R Arshady, J Kreuter, P Groscurth, P P Speiser.   

Abstract

[14C]Polyhexyl cyanoacrylate nanoparticles (PHCA), with diameters between 200 and 300 nm, were injected intravenously into nude mice bearing a human osteosarcoma. The distribution in liver, spleen, lung, heart, kidney, GI tract, gonads, brain, muscle, as well as in serum and transplanted tumor fragments was investigated by liquid scintillation counting. The peak levels in all organs with the exception of tumor and spleen were reached within 24 h. The highest levels were found in the organs of the reticuloendothelial system, liver, spleen, and lungs. The radioactivity in the other organs was found to be low, approximately 2%. In the tumor and the spleen the highest levels of radioactivity were found at approximately 7 d. At this stage the level of radioactivity in the tumor was 40 times higher than that in muscle. However, the amount of isotope detected in the tumor was still generally less than 1% of the injected dose. The concentration of radioactivity in the tumor was found to be quite variable. Higher levels of radioactivity were correlated with a low amount of tumor necrosis indicating the importance of viable tumor tissue for the accumulation of the radiolabel in this particular animal model.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3457949     DOI: 10.1002/jps.2600750310

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

Review 1.  Nanoparticles: a promising modality in the treatment of sarcomas.

Authors:  Michiro Susa; Lara Milane; Mansoor M Amiji; Francis J Hornicek; Zhenfeng Duan
Journal:  Pharm Res       Date:  2010-05-27       Impact factor: 4.200

2.  Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.

Authors:  J Lode; I Fichtner; J Kreuter; A Berndt; J E Diederichs; R Reszka
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

3.  M13 phage peptide ZL4 exerts its targeted binding effect on schistosoma japonicum via alkaline phosphatase.

Authors:  Yan Liu; Shenghui Yang; Jianhua Xiao; Liang Yu; Li Chen; Ju Zou; Kegeng Wang; Sijie Tan; Zhengyang Yu; Qingren Zeng
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  Drug targeting with nanoparticles.

Authors:  J Kreuter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

5.  Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice.

Authors:  M Youssef; E Fattal; M J Alonso; L Roblot-Treupel; J Sauzières; C Tancrède; A Omnès; P Couvreur; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

6.  Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats.

Authors:  P Maincent; P Thouvenot; C Amicabile; M Hoffman; J Kreuter; P Couvreur; J P Devissaguet
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

7.  Mitochondrial transplantation attenuates hypoxic pulmonary hypertension.

Authors:  Liping Zhu; Jiwei Zhang; Juan Zhou; Yankai Lu; Songling Huang; Rui Xiao; Xiangyuan Yu; Xianqin Zeng; Bingxun Liu; Fangbo Liu; Mengxiang Sun; Mao Dai; Qiang Hao; Jiansha Li; Tao Wang; Tongfei Li; Qinghua Hu
Journal:  Oncotarget       Date:  2016-08-02

Review 8.  Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery.

Authors:  Ji Young Yhee; Jintaek Im; Richard Seonghun Nho
Journal:  J Clin Med       Date:  2016-09-20       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.